DeepSeek's claim that its R1 artificial intelligence ... Javier Aguirre, an AI researcher at Samsung Medical Center in Seoul, South Korea, specialises in researching in medicine and AI.

As of early March, at least 300 hospitals in China have started using DeepSeek’s large language models (LLMs) in clinical diagnostics and medical decision support.

DeepSeek is an AI platform based on deep learning and natural language processing, featuring core products DeepSeek-R1 and DeepSeek-V3 models. Using efficient Mixture of Experts (MoE) architecture ...

As of early March, at least 300 hospitals in China have started using DeepSeek's large language models (LLMs) in clinical diagnostics and medical decision support.

Medicine: Deepseek AI accelerates drug discovery by simulating molecular interactions, predicting treatment outcomes, and identifying potential therapeutic targets.

As of early March, at least 300 hospitals in China have started using DeepSeek’s large language models (LLMs) in clinical diagnostics and medical decision support.

DeepSeek-R1’s standout feature is its ability to decompose complex problems using chain-of-thought (CoT) reasoning, reinforced by a multi-stage training pipeline. This includes pretraining on diverse ...

DeepSeek’s market position. DeepSeek now holds a global market share of 6.58%, placing it third among AI tools. It trails behind ChatGPT, which leads with 43.16%, and Canva, which has an 8.27% ...